期刊
NEUROPSYCHOLOGY REVIEW
卷 17, 期 2, 页码 179-188出版社
SPRINGER
DOI: 10.1007/s11065-007-9023-0
关键词
functional magnetic resonance imaging; drug development; anxiety; pharmacology; biomarkers
资金
- NIMH NIH HHS [MH64122, MH075792, R01 MH075792-02, MH65413, R01 MH075792] Funding Source: Medline
In this review, we survey the state of the field of functional magnetic resonance imaging (fMRI) as it relates to drug discovery and drug development. We highlight the advantages and limitations of fMRI for this purpose and suggest ways to improve the use of fMRI for developing new therapeutics, with emphasis on treatments for anxiety disorders. Fundamentally, pharmacological studies with standard psychiatric treatments using standardized behavioral probes during fMRI will need to be carried out to determine characteristic brain signatures that could be used to predict whether novel compounds are likely to have specific therapeutic effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据